Should beta-blockers, calcium channel blockers, ACE inhibitors, and ARBs be stopped or continued before ambulatory anesthesia in patients with hypertension and ischemic heart disease?
Patients undergoing ambulatory surgery can likely continue all cardiac medications, including ACE inhibitors and ARBs, as intraoperative hypotension is easily managed without adverse outcomes.
PURPOSE OF REVIEW: As day surgery continues to expand, more patients will be encountered who are chronically taking a range of cardiovascular medications for the management of hypertension and ischaemic heart disease. This review will consider the available evidence relating to whether or not these medications should be continued throughout the perioperative period in ambulatory surgical patients. RECENT FINDINGS: There has been relatively little research in this area which is specific to ambulatory surgery and much of the available evidence from major surgery has been assembled over the many years that these medications have been in use. In order to provide a comprehensive and balanced review, we have considered relevant evidence outside of the usual review period. SUMMARY: Patients should continue to take beta-blockers and calcium channel blockers on the day of surgery. Continuing angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers increases the likelihood of intraoperative hypotension. This can be reduced by withholding these drugs, but will also respond to simple treatments without any apparent adverse outcomes. It may therefore simplify instructions to patients if they are told to take all cardiac medications as normal.
Smith et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: